Published in Nucleic Acids Res on January 15, 2001
SF1 and SF2 helicases: family matters. Curr Opin Struct Biol (2010) 3.79
RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP. Nature (2006) 3.67
The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO J (2002) 2.52
The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target. Curr Issues Mol Biol (2007) 1.76
When a helicase is not a helicase: dsDNA tracking by the motor protein EcoR124I. EMBO J (2006) 1.51
NS3 helicase actively separates RNA strands and senses sequence barriers ahead of the opening fork. Proc Natl Acad Sci U S A (2007) 1.50
Understanding helicases as a means of virus control. Curr Pharm Des (2006) 1.18
Inhibition of BACH1 (FANCJ) helicase by backbone discontinuity is overcome by increased motor ATPase or length of loading strand. Nucleic Acids Res (2006) 1.15
Endocytic Rab proteins are required for hepatitis C virus replication complex formation. Virology (2009) 1.14
CLPM: a cross-linked peptide mapping algorithm for mass spectrometric analysis. BMC Bioinformatics (2005) 1.08
NS3 helicase from the hepatitis C virus can function as a monomer or oligomer depending on enzyme and substrate concentrations. J Biol Chem (2008) 1.04
Vinylphosphonate internucleotide linkages inhibit the activity of PcrA DNA helicase. Biochemistry (2002) 0.97
Conserved GXXXG- and S/T-like motifs in the transmembrane domains of NS4B protein are required for hepatitis C virus replication. J Virol (2011) 0.95
Structurally conserved amino Acid w501 is required for RNA helicase activity but is not essential for DNA helicase activity of hepatitis C virus NS3 protein. J Virol (2003) 0.92
Non-Watson-Crick interactions between PNA and DNA inhibit the ATPase activity of bacteriophage T4 Dda helicase. Nucleic Acids Res (2002) 0.89
Mechanistic and biological aspects of helicase action on damaged DNA. Cell Cycle (2010) 0.86
Measurement of steady-state kinetic parameters for DNA unwinding by the bacteriophage T4 Dda helicase: use of peptide nucleic acids to trap single-stranded DNA products of helicase reactions. Nucleic Acids Res (2001) 0.84
Unzippers, resolvers and sensors: a structural and functional biochemistry tale of RNA helicases. Int J Mol Sci (2015) 0.81
Switching from single-stranded to double-stranded DNA limits the unwinding processivity of ring-shaped T7 DNA helicase. Nucleic Acids Res (2013) 0.81
Close encounters for the first time: Helicase interactions with DNA damage. DNA Repair (Amst) (2015) 0.80
Melting of Duplex DNA in the Absence of ATP by the NS3 Helicase Domain through Specific Interaction with a Single-Strand/Double-Strand Junction. Biochemistry (2015) 0.78
Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis. J Biol Chem (2013) 0.78
Binding by the hepatitis C virus NS3 helicase partially melts duplex DNA. Biochemistry (2012) 0.78
Double-stranded DNA-induced localized unfolding of HCV NS3 helicase subdomain 2. Protein Sci (2003) 0.78
PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature (1993) 8.83
Crystal structures of complexes of PcrA DNA helicase with a DNA substrate indicate an inchworm mechanism. Cell (1999) 6.84
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure (1998) 5.83
Mechanisms of helicase-catalyzed DNA unwinding. Annu Rev Biochem (1996) 5.81
Major domain swiveling revealed by the crystal structures of complexes of E. coli Rep helicase bound to single-stranded DNA and ADP. Cell (1997) 4.71
Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol (1997) 3.80
Antisense and antigene properties of peptide nucleic acids. Science (1992) 3.04
Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology (1998) 2.76
DNA helicases: enzymes with essential roles in all aspects of DNA metabolism. Bioessays (1994) 2.65
Uncoupling DNA translocation and helicase activity in PcrA: direct evidence for an active mechanism. EMBO J (2000) 2.27
Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli. Protein Expr Purif (1999) 2.24
Escherichia coli rep helicase unwinds DNA by an active mechanism. Biochemistry (1993) 2.14
Allosteric effects of nucleotide cofactors on Escherichia coli Rep helicase-DNA binding. Science (1992) 2.04
Helicases: a unifying structural theme? Curr Opin Struct Biol (1998) 1.81
Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol (1998) 1.54
Solution structure of a peptide nucleic acid-DNA duplex. Nat Struct Biol (1996) 1.48
Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA. J Biol Chem (1998) 1.44
Strand-specific recognition of a synthetic DNA replication fork by the SV40 large tumor antigen. Science (1992) 1.39
Sequence-specific transcription arrest by peptide nucleic acid bound to the DNA template strand. Gene (1994) 1.39
Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells. Oncogene (1999) 1.31
NMR solution structure of a peptide nucleic acid complexed with RNA. Science (1994) 1.29
Bacteriophage T4 Dda helicase translocates in a unidirectional fashion on single-stranded DNA. J Biol Chem (1995) 1.26
Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem Biol (1999) 1.16
The nonstructural proteins of the hepatitis C virus: structure and functions. Biol Chem (1997) 1.10
Peptide nucleic acids as therapeutic agents. Curr Opin Struct Biol (1999) 0.98
Homomorphous hexameric helicases: tales from the ring cycle. Structure (1996) 0.96
Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning. Biochemistry (1997) 0.94
Structure and stability of the consecutive stereoregulated chiral phosphorothioate DNA duplex. Biochemistry (1999) 0.94
Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates. Biochemistry (2000) 0.93
Strand-separating activity of hepatitis C virus helicase in the absence of ATP. Biochemistry (2000) 0.87
A simple procedure for solid-phase synthesis of peptide nucleic acids with N-terminal cysteine. Bioorg Med Chem Lett (1998) 0.84
Inhibition of a DNA-helicase by peptide nucleic acids. Nucleic Acids Res (1999) 0.83
Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature (1995) 6.16
Effect of ibuprofen on cardioprotective effect of aspirin. Lancet (2003) 6.07
An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol (1994) 5.87
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med (2000) 5.73
Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res (2012) 5.57
RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A (2001) 5.21
Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet (1993) 4.78
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol (1996) 3.97
The Caenorhabditis elegans unc-64 locus encodes a syntaxin that interacts genetically with synaptobrevin. Mol Biol Cell (1998) 2.70
Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med (1993) 2.58
Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants. J Neurosci (1998) 2.57
Neuronal units linked to microvascular modules in cerebral cortex: response elements for imaging the brain. Cereb Cortex (1997) 2.54
Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub). J Biol Chem (2000) 2.41
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol (2007) 2.35
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest (1997) 2.33
Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli. Protein Expr Purif (1999) 2.24
A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase. Virology (2001) 2.21
UNC-11, a Caenorhabditis elegans AP180 homologue, regulates the size and protein composition of synaptic vesicles. Mol Biol Cell (1999) 2.16
Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase. Methods Enzymol (1995) 2.01
Poliovirus RNA-dependent RNA polymerase (3Dpol): structural, biochemical, and biological analysis of conserved structural motifs A and B. J Biol Chem (2000) 1.98
Statistical approaches for assessing the relative validity of a food-frequency questionnaire: use of correlation coefficients and the kappa statistic. Public Health Nutr (2003) 1.88
Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J Biol Chem (2001) 1.85
Multiple sclerosis lesion quantification using fuzzy-connectedness principles. IEEE Trans Med Imaging (1997) 1.82
DNA helicases displace streptavidin from biotin-labeled oligonucleotides. Biochemistry (1999) 1.82
New patterns of intracortical projections after focal cortical stroke. Neurobiol Dis (2001) 1.81
Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke (2000) 1.77
Accuracy of NHANES periodontal examination protocols. J Dent Res (2010) 1.73
Self-reported measures for surveillance of periodontitis. J Dent Res (2013) 1.69
Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 1.63
Poliovirus RNA-dependent RNA polymerase (3Dpol) is sufficient for template switching in vitro. J Biol Chem (1999) 1.62
A comparison between B-type natriuretic peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification. Heart (2009) 1.59
Calcium-activated chloride channels in bovine pulmonary artery endothelial cells. J Physiol (1997) 1.55
Poliovirus RNA-dependent RNA polymerase (3D(pol)). Divalent cation modulation of primer, template, and nucleotide selection. J Biol Chem (1999) 1.53
Complete nucleotide sequence of Kashmir bee virus and comparison with acute bee paralysis virus. J Gen Virol (2004) 1.49
A meta-analysis of epidemiological studies in depression of older people in the People's Republic of China. Int J Geriatr Psychiatry (1999) 1.46
Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem (1993) 1.45
Measuring prenatal drug exposure. J Pediatr Nurs (2001) 1.40
Serial analysis of magnetization-transfer histograms and Expanded Disability Status Scale scores in patients with relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol (2000) 1.40
Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer (1993) 1.38
Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int (2001) 1.32
Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32
Activation of Indian hedgehog promotes chondrocyte hypertrophy and upregulation of MMP-13 in human osteoarthritic cartilage. Osteoarthritis Cartilage (2012) 1.26
Proteinase-polymerase precursor as the active form of feline calicivirus RNA-dependent RNA polymerase. J Virol (2001) 1.24
Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology (2000) 1.23
Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm Res (1996) 1.22
Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differentiation by parathyroid hormone. J Biol Chem (2000) 1.21
Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. J Biol Chem (1992) 1.20
Mutations that alter the activity of the Rous sarcoma virus protease. J Biol Chem (1992) 1.20
Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning. Cell Death Dis (2010) 1.19
Truncating alpha-helix E' of p66 human immunodeficiency virus reverse transcriptase modulates RNase H function and impairs DNA strand transfer. J Biol Chem (1995) 1.17
IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection. J Viral Hepat (2011) 1.16
A range of catalytic efficiencies with avian retroviral protease subunits genetically linked to form single polypeptide chains. J Biol Chem (1991) 1.15
Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice. Neuroscience (2006) 1.14
Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev (2006) 1.12
Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells. Cancer Gene Ther (2008) 1.11
Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats. Diabetes Obes Metab (2010) 1.11
Evidence for a functional monomeric form of the bacteriophage T4 DdA helicase. Dda does not form stable oligomeric structures. J Biol Chem (2001) 1.08
Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites. J Biol Chem (1996) 1.07
Downregulation of volume-activated Cl- currents during muscle differentiation. Am J Physiol (1997) 1.07
Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase. Biochemistry (1995) 1.07
Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site. J Biol Chem (1993) 1.07
Intracranial pressure fluctuation during hemodialysis in renal failure patients with intracranial hemorrhage. Acta Neurochir Suppl (2008) 1.07
A case-control study of nasopharyngeal carcinoma in the high background radiation areas of Yangjiang, China. J Radiat Res (2000) 1.06
Cancer mortality in the high background radiation areas of Yangjiang, China during the period between 1979 and 1995. J Radiat Res (2000) 1.05
Tissue composition affects measures of postabsorptive human skeletal muscle metabolism: comparison across genders. J Clin Endocrinol Metab (1999) 1.05
Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum Mol Genet (1998) 1.05
Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem (1995) 1.05
Review of guidelines and literature for handling missing data in longitudinal clinical trials with a case study. Pharm Stat (2006) 1.04
Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women. Am J Med (1997) 1.04
Unwinding of unnatural substrates by a DNA helicase. Biochemistry (2001) 1.03
Biotin-streptavidin-labeled oligonucleotides as probes of helicase mechanisms. Methods (2001) 1.02
New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins. Antimicrob Agents Chemother (2001) 1.02
Branched chain amino acids activate messenger ribonucleic acid translation regulatory proteins in human skeletal muscle, and glucocorticoids blunt this action. J Clin Endocrinol Metab (2001) 1.01
7,12-dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic Biol Med (1995) 1.00
Free radical-mediated neurotoxicity may be caused by inhibition of mitochondrial dehydrogenases in vitro and in vivo. Neuroscience (2006) 1.00
Kinetic analysis of nucleotide incorporation and misincorporation by Klenow fragment of Escherichia coli DNA polymerase I. Methods Enzymol (1995) 1.00
Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Res (1994) 0.97
Hypercapnia slightly raises blood volume and sizably elevates flow velocity in brain microvessels. Am J Physiol (1993) 0.97
MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol (2000) 0.96
Store-front churches in the inner city. Ment Hyg (1970) 0.95
Integrin signaling's potential for mediating gene expression in hypertrophying skeletal muscle. J Appl Physiol (1985) (2000) 0.95
Multiple sclerosis: magnetization transfer histogram analysis of segmented normal-appearing white matter. Radiology (2000) 0.95
Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site. J Biol Chem (1994) 0.95
Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. J Viral Hepat (2010) 0.94
Hypoxia increases velocity of blood flow through parenchymal microvascular systems in rat brain. J Cereb Blood Flow Metab (1993) 0.94
Chromosome-damaging activity of ferritin and its relation to chelation and reduction of iron. Cancer Res (1981) 0.93
Using meta computing tools to facilitate large-scale analyses of biological databases. Pac Symp Biocomput (2001) 0.93
Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol (1998) 0.93
Are there adverse consequences of quizzing during informed consent for HIV research? J Med Ethics (2011) 0.93
KAI1 protein is down-regulated during the progression of human breast cancer. Clin Cancer Res (2000) 0.92
Numerical tissue characterization in MS via standardization of the MR image intensity scale. J Magn Reson Imaging (2000) 0.92
Physiological hyperinsulinemia stimulates p70(S6k) phosphorylation in human skeletal muscle. J Clin Endocrinol Metab (2000) 0.92
Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology (1998) 0.92
Inhibition of volume-regulated and calcium-activated chloride channels by the antimalarial mefloquine. J Pharmacol Exp Ther (2000) 0.92
Characterization of the Lactobacillus helveticus groESL operon. Res Microbiol (1998) 0.92
Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice. Neuroscience (2013) 0.91
Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses. Chem Res Toxicol (1992) 0.91
Cycloheximide reduces infarct volume when administered up to 6 h after mild focal ischemia in rats. Brain Res (2001) 0.91
Programming the Rous sarcoma virus protease to cleave new substrate sequences. J Biol Chem (1996) 0.91